Le Lézard
Classified in: Business
Subject: ACC

The Prospect Japan Fund Issues Notice Regarding Adjustment of Exercise Price of Stock Acquisition Rights (Stock Options)


ST. PETER PORT, Guernsey, September 5, 2017 /PRNewswire/ --

In connection with the issuance of new shares by the Company, which was published in the "Notice regarding Agreement on Commencement of a Friendly Acquisition Procedure to Make The Prospect Japan Fund a Wholly-owned Subsidiary and Proposals to be Presented at the Annual Shareholders Meeting" as of May 31, 2017 and the "Notice regarding Terms of Issuance of Common Stock" as of June 1, 2017, the exercise price of all stock acquisition rights (stock options) issued by the Company has been adjusted and we hereby notify you as follows.

1.    Adjustment of Exercise Price


   
      Name of Stock Acquisition Rights          Exercise Price      Exercise Price
              (Stock Options)                   before Adjustment   after Adjustment
    1st Stock Acquisition Rights (Stock              61 yen            56 yen
    Options)
    (Issued on August 1, 2013)                      


    2nd Stock Acquisition Rights (Stock              60 yen            55 yen
    Options)
    (Issued on October 18, 2013)                    

    3rd Stock Acquisition Rights                     54 yen           49.2 yen
    (Issued on December 21, 2015)                   

    4th Stock Acquisition Rights (Stock              52 yen            48 yen
    Options)
   (Issued on January 6, 2016)                     

*    Each of the above prices is the exercise price per share.

*    As for the 3rd Stock Acquisition Rights, since the adjustment price due to issuance of the 4th Stock Acquisition Rights (Stock Options) (January 16, 2016) was less than one yen and since the price adjustment was carried forward to the next time, such adjustment carried forward was added to the current adjustment (?0.2 yen).

2.    Effective Date of Adjustment

July 28, 2017

3.    Reasons for Adjustment

As the issuance of the new shares set forth above fell under the reasons for adjustment of exercise price, which are provided for in the prescribed issuance requirements of each Stock Acquisition Rights (Stock Options).

Prospect Co., Ltd.
Representative Director, President: Curtis Freeze
(Code Number: 3528, 2nd Section of TSE)
Contact:
Representative Director, Managing Director, Masato Tabata
TEL: 03-(3470)-8411 (Main)


These press releases may also interest you

at 23:00
Cybervation, an award-winning global technology and healthcare solutions company, proudly announces that its CEO, Purba Majumder, has been distinguished as one of the 2024 100 Women to KNOW Across America. This award from KNOW Women recognizes...

at 22:30
Blue Owl Capital Inc. ("Blue Owl") , a leading alternative asset manager, announced today the hiring of Alicia Gregory as a Managing Director based in Sydney.   Alicia brings over 25 years of investing experience with deep relationships and...

at 22:00
Zetrix Foundation and MY E.G. Services Berhad ("MYEG") signed a Memorandum of Understanding (MoU) with MaiCapital, a licensed virtual asset manager in Hong Kong, to collaborate on the launch of a virtual asset fund or Hong Kong virtual assets...

at 21:38
Grupo Elektra, S.A.B. de C.V. (BMV: ELEKTRA* Latibex: XEKT), Latin America's leading specialty retailer and financial services company, and the largest non-bank provider of...

at 21:30
O2Gold Inc. (NEX: OTGO.H) ("O2Gold" or the "Company") is pleased to announce that it has entered into a share exchange agreement dated March 21, 2024 (the "Agreement") with Quebec Aur Ltd., a private Ontario corporation, (the "Target") and its...

at 21:27
Hanmi Pharmaceutical (KOSPI: 128940, CEO: Jae-Hyun Park), a leading biopharma company in Korea that focuses on research areas such as oncology, obesity/metabolism, and rare diseases, announced it has entered into a Clinical Trial Collaboration and...



News published on and distributed by: